These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36313441)

  • 1. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer.
    Li K; Wang W
    Front Genet; 2022; 13():981392. PubMed ID: 36313441
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
    Gao Y; Ren J; Chen K; Guan G
    J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
    Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
    Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
    Front Immunol; 2022; 13():984149. PubMed ID: 36300121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
    Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
    BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
    Front Genet; 2022; 13():929035. PubMed ID: 36081998
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
    Huang Z; Lou K; Liu H
    Front Genet; 2022; 13():1030275. PubMed ID: 36313442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S
    Front Genet; 2022; 13():906496. PubMed ID: 35938009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
    Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
    Front Genet; 2022; 13():930446. PubMed ID: 36110218
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
    Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
    Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
    Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
    EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.
    Wang H; Shui X; Zhang Z; He M; Tai S; Lin Y
    Transl Cancer Res; 2024 Jun; 13(6):2799-2811. PubMed ID: 38988942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel m7G-Related Gene Signature Predicts the Prognosis of Colon Cancer.
    Chen J; Song YW; Liang GZ; Zhang ZJ; Wen XF; Li RB; Chen YL; Pan WD; He XW; Hu T; Xian ZY
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
    Xie S; He J; Feng B; Rao D; Wang S; He Y
    Heliyon; 2023 May; 9(5):e15897. PubMed ID: 37215925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
    J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
    Li Z; Wang W; Wu J; Ye X
    Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.